Artwork

Inhoud geleverd door The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

OUD Treatment and Intent To Treat Analysis

20:02
 
Delen
 

Manage episode 276352129 series 2818069
Inhoud geleverd door The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

X:BOT primary outcomes

We discuss the X:BOT primary outcomes paper in this episode of the podcast. Use the link above or the citation below to find it. Take a look at the figures!

JD Lee et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicenter, open-label, randomized controlled trial. Lancet 2018. 391:309-318.

X:BOT rationale and design paper

In this fascinating and thoughtful paper, the X:BOT authors discuss the study design choices they considered and how they selected various aspects of the trial design. A great read for those with interest in OUD treatment or clinical trials design.

X:BOT cost effectiveness analysis

This planned analysis of the X:BOT data provides an additional lens for determining which medication is the best option.

A great buprenorphine review

Thorough but brief review on the use of buprenorphine.

  continue reading

11 afleveringen

Artwork
iconDelen
 
Manage episode 276352129 series 2818069
Inhoud geleverd door The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

X:BOT primary outcomes

We discuss the X:BOT primary outcomes paper in this episode of the podcast. Use the link above or the citation below to find it. Take a look at the figures!

JD Lee et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicenter, open-label, randomized controlled trial. Lancet 2018. 391:309-318.

X:BOT rationale and design paper

In this fascinating and thoughtful paper, the X:BOT authors discuss the study design choices they considered and how they selected various aspects of the trial design. A great read for those with interest in OUD treatment or clinical trials design.

X:BOT cost effectiveness analysis

This planned analysis of the X:BOT data provides an additional lens for determining which medication is the best option.

A great buprenorphine review

Thorough but brief review on the use of buprenorphine.

  continue reading

11 afleveringen

Minden epizód

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding